Last quarter (Q3 2023), Anika Therapeutics's total revenue was $41.47M, an increase of 2.98% from the same quarter last year. In Q3, Anika Therapeutics's net income was $-6.58M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 163.31M	$ 156.24M	$ 147.79M	$ 130.46M	$ 114.61M	$ 105.56M
Cost of Revenue	$ 1.28M	$ 62.66M	$ -64.85M	$ 61.43M	$ 28.75M	$ 31.28M
Gross Profit	$ 100.89M	$ 93.58M	$ 82.94M	$ 69.03M	$ 85.86M	$ 74.28M
Operating Expense	$ 60.62M	$ 112.98M	$ 101.42M	$ 83.49M	$ 51.62M	$ 52.53M
Operating Income	$ 70.43M	$ -19.40M	$ -18.48M	$ -14.47M	$ 34.25M	$ 21.75M
Net Non Operating Interest Income Expense	$ 2.01M	$ 654.00K	$ -188.00K	$ -302.00K	$ 1.87M	$ 1.46M
Other Income Expense	$ -286.00K	$ -180.00K	$ -21.09M	$ -13.85M	-	-
Pretax Income	$ -28.51M	$ -18.75M	$ 2.43M	$ -28.62M	$ 36.12M	$ 23.21M
Tax Provision	$ -611.00K	$ -3.89M	$ -1.71M	$ -4.64M	$ 8.93M	$ 4.49M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 73.05M	$ -14.86M	$ 4.13M	$ -23.98M	$ 27.19M	$ 18.72M
Basic EPS	$ -1.68	$ -1.02	$ 0.29	$ -1.69	$ 1.93	$ 1.30
Diluted EPS	$ -1.68	$ -1.02	$ 0.28	$ -1.69	$ 1.89	$ 1.27
Basic Average Shares	$ 58.54M	$ 14.56M	$ 14.40M	$ 14.22M	$ 14.12M	$ 14.44M
Diluted Average Shares	$ 58.54M	$ 14.56M	$ 14.63M	$ 14.22M	$ 14.37M	$ 14.69M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	$ 0.71	$ 2.05	$ 1.27
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 61.90M	$ 175.64M	$ 36.57M	$ 144.93M	$ 80.36M	$ 83.81M
Net Income From Continuing And Discontinued Operation	$ -24.57M	$ -14.86M	$ 4.13M	$ -23.98M	$ 27.19M	$ 18.72M
Normalized Income	$ -10.90M	-	-	$ -12.37M	$ 27.19M	$ 18.72M
Interest Expense	-	-	-	-	-	-
EBIT	$ -28.79M	$ -18.73M	$ 2.41M	$ -14.47M	$ 34.25M	$ 21.75M
EBITDA	$ -12.32M	$ -2.40M	$ 24.90M	$ -1.00M	$ 40.24M	$ 27.66M

Currency in USD

Anika Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing